Literature DB >> 18474617

Combined VHLH and PTEN mutation causes genital tract cystadenoma and squamous metaplasia.

Ian J Frew1, Andrea Minola, Strahil Georgiev, Manuela Hitz, Holger Moch, Stéphane Richard, Alexander O Vortmeyer, Wilhelm Krek.   

Abstract

Patients with von Hippel-Lindau (VHL) disease develop tumors in a range of tissues, but existing mouse models of Vhlh mutation have failed to reproduce these lesions. Epididymal cystadenomas arise frequently in VHL patients, but VHL mutation alone is believed to be insufficient for tumor formation, implying a requirement for cooperating mutations in epididymal pathogenesis. Here we show that epididymal cystadenomas from VHL patients frequently also lack expression of the PTEN tumor suppressor and display activation of phosphatidylinositol 3-kinase (PI3K) pathway signaling. Strikingly, while conditional inactivation of either Vhlh or Pten in epithelia of the mouse genital tract fails to produce a tumor phenotype, their combined deletion causes benign genital tract tumors with regions of squamous metaplasia and cystadenoma. The latter are histologically identical to lesions found in VHL patients. Importantly, these lesions are characterized by expansion of basal stem cells, high levels of expression and activity of HIF1alpha and HIF2alpha, and dysregulation of PI3K signaling. Our studies suggest a model for cooperative tumor suppression in which inactivation of PTEN facilitates epididymal cystadenoma genesis initiated by loss of VHL.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18474617      PMCID: PMC2447121          DOI: 10.1128/MCB.02132-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  52 in total

1.  Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene.

Authors:  Ralf Lesche; Matthias Groszer; Jing Gao; Ying Wang; Albee Messing; Hong Sun; Xin Liu; Hong Wu
Journal:  Genesis       Date:  2002-02       Impact factor: 2.487

2.  Notch signaling is required for normal prostatic epithelial cell proliferation and differentiation.

Authors:  Xi-De Wang; Ching Ching Leow; Jiping Zha; Zhijun Tang; Zora Modrusan; Freddy Radtke; Michel Aguet; Frederic J de Sauvage; Wei-Qiang Gao
Journal:  Dev Biol       Date:  2005-12-15       Impact factor: 3.582

3.  Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation.

Authors:  Shunyou Wang; Alejandro J Garcia; Michelle Wu; Devon A Lawson; Owen N Witte; Hong Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

4.  Generalized lacZ expression with the ROSA26 Cre reporter strain.

Authors:  P Soriano
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

Review 5.  Sexual differentiation.

Authors:  J D Wilson
Journal:  Annu Rev Physiol       Date:  1978       Impact factor: 19.318

6.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

7.  Inactivation of the PTEN gene by mutation, exonic deletion, and loss of transcript in human oral squamous cell carcinomas.

Authors:  Ki-Hyuk Shin; Jin-Man Kim; Kyong Su Rho; Kyung-Hee Park; Ju-Eun Oh; Byung-Moo Min
Journal:  Int J Oncol       Date:  2002-11       Impact factor: 5.650

8.  Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor.

Authors:  V H Haase; J N Glickman; M Socolovsky; R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

Review 9.  Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty.

Authors:  Boudewijn M T Burgering; René H Medema
Journal:  J Leukoc Biol       Date:  2003-06       Impact factor: 4.962

Review 10.  von Hippel-Lindau disease.

Authors:  Russell R Lonser; Gladys M Glenn; McClellan Walther; Emily Y Chew; Steven K Libutti; W Marston Linehan; Edward H Oldfield
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

View more
  21 in total

Review 1.  Renal cancer: oxygen meets metabolism.

Authors:  Volker H Haase
Journal:  Exp Cell Res       Date:  2012-03-03       Impact factor: 3.905

2.  An analysis of five clear cell papillary cystadenomas of mesosalpinx and broad ligament: four associated with von Hippel-Lindau disease and one aggressive sporadic type.

Authors:  Francisco F Nogales; Pablo Goyenaga; Ovidiu Preda; Alina Nicolae; Begoña Vieites; Maria Carmen Ruiz-Marcellan; Alberto Pedrosa; Maria J Merino
Journal:  Histopathology       Date:  2012-02-01       Impact factor: 5.087

3.  Elongin C is a mediator of Notch4 activity in human renal tubule cells.

Authors:  Timothy D Cummins; Michael D Mendenhall; Michelle N Lowry; Erik A Korte; Michelle T Barati; Syed J Khundmiri; Sarah A Salyer; Jon B Klein; David W Powell
Journal:  Biochim Biophys Acta       Date:  2011-10-05

4.  Activated mutant p110α causes endometrial carcinoma in the setting of biallelic Pten deletion.

Authors:  Ayesha Joshi; Christopher Miller; Suzanne J Baker; Lora H Ellenson
Journal:  Am J Pathol       Date:  2015-02-16       Impact factor: 4.307

Review 5.  Von Hippel-Lindau disease (VHL): a need for a murine model with retinal hemangioblastoma.

Authors:  Stanley Park; Chi-Chao Chan
Journal:  Histol Histopathol       Date:  2012-08       Impact factor: 2.303

Review 6.  Why are epididymal tumours so rare?

Authors:  Ching-Hei Yeung; Kai Wang; Trevor G Cooper
Journal:  Asian J Androl       Date:  2012-04-23       Impact factor: 3.285

7.  VHL loss causes spindle misorientation and chromosome instability.

Authors:  Claudio R Thoma; Alberto Toso; Katrin L Gutbrodt; Sabina P Reggi; Ian J Frew; Peter Schraml; Alexander Hergovich; Holger Moch; Patrick Meraldi; Wilhelm Krek
Journal:  Nat Cell Biol       Date:  2009-07-20       Impact factor: 28.824

8.  [p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumor aggressiveness in humans].

Authors:  P J Wild
Journal:  Pathologe       Date:  2013-11       Impact factor: 1.011

Review 9.  The VHL tumor suppressor: master regulator of HIF.

Authors:  Volker H Haase
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

10.  Clustering of sebaceous gland carcinoma, papillary thyroid carcinoma and breast cancer in a woman as a new cancer susceptibility disorder: a case report.

Authors:  Brian D Newman; Joseph F Maher; Jose S Subauste; Gabriel I Uwaifo; Steven A Bigler; Christian A Koch
Journal:  J Med Case Rep       Date:  2009-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.